Evidence suggests that excessive inflammatory process activation leads to abundant interleukin-1β (IL-1β) release and subsequent aggravation of pulmonary injury and induce hypercoagulability, favoring progression to respiratory failure and widespread thrombosis eventually leading to multi-organ failure and death (Nicola et al. 2022). The gene discussed is IL1B; the disease is thrombophilia.